Biotechnology

Techseriesinsight > Blog > News > Biotechnology

two person handshaking which shows partnership, Atombeat-and-BioDuro-Announce-Strategic.jpg

August 1, 2025
PRNewswire
Artificial Intelligence, Biotechnology, News

New Platform Speeds Peptide Drug Discovery with AI & Synthesis

On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), announced a strategic collaboration to an AI powered platform for...

doctor in lab, Energenesis-Biomedical-Announces-Positive

August 1, 2025
PRNewswire
Biotechnology, Healthcare, News

Energenesis Announces Successful Phase I Trial for Parkinson’s Therapy

Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biotechnology company focused on cellular energy restoration therapeutics, today announced the successful completion of its Phase I clinical trial for ENERGI-F705PD,...

July 30, 2025
Business Wire
Biotechnology, Healthcare, News

NeoGenomics Expands PanTracer Portfolio with LBx Launch

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of NEO PanTracer™ LBx, a blood-based comprehensive genomic profiling (CGP) test,...

July 30, 2025
PRNewswire
Biotechnology, Healthcare, News

MAGENTIQ‑COLO AI Platform Receives Series A to Drive Innovation

MAGENTIQ EYE LTD., a leading innovator in AI-powered gastroenterology decision-support software, today announced the successful completion of its Series A funding round. MAGENTIQ EYE’s FDA- and CE-approved software, MAGENTIQ-COLO™, enhances polyp...

July 29, 2025
PRNewswire
Artificial Intelligence, Biotechnology, Healthcare, News

Simulations Plus and IMB Validate AIDD Module in ADMET Predictor

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that experimental...

July 29, 2025
PRNewswire
Biotechnology, News

Hope in New Alzheimer’s Blood Test

TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a strategic collaboration with T-NeuroDx, a pioneering diagnostics company dedicated to developing innovative solutions for detecting neurodegenerative diseases,...

July 28, 2025
PRNewswire
Artificial Intelligence, Biotechnology, News

BATMAN brings TCR therapy out of the shadows

Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment....

July 28, 2025
PRNewswire
Biotechnology, Healthcare, News

Cognito Showcases Spectris™ Alzheimer’s Trial Results at AAIC 2025

Cognito Therapeutics, a clinical-stage neurotechnology company pioneering neuromodulation-based treatments for neurodegenerative diseases, announced five new poster presentations at the Alzheimer’s Association International Conference (AAIC) 2025 supporting the clinical efficacy...

July 25, 2025
Business Wire
Biotechnology, Healthcare, News

ImmunityBio Secures $80 Million in Direct Offering with Institutional Investors

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that it has executed financing to provide further working capital and support its ongoing business operations. The Company entered...

July 25, 2025
Business Wire
Biotechnology, Healthcare, News

Cristian Massacesi Becomes EVP & CMO at BMS

Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cristian Massacesi, M.D., as Executive Vice President, Chief Medical Officer, and Head of Development, effective August 1, 2025. In...